New technology gives important knowledge of myeloproliferative neoplasms
At this year’s ASH Meeting, Shira Rosenberg shared the results of genotyping of transcriptomes of CALR-mutated essential thrombocythemia patients. The study revealed that interferon-alpha promotes early lymphoid development and, uniquely in CALR mutated cells myeloid differentiation, providing a novel mechanism of actions underlying the effects of interferon-alpha in patients with myeloproliferative neoplasms.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in